Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization

Clinical and Experimental Allergy

Volumn 35, Issue 6, 2005, Pages 757-766

  Strid, Jessica ^a   Hourihane, J ^b   Kimber, I ^c   Callard, R ^a   Strobel, S ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c JEALOTT S HILL INTERNATIONAL RESEARCH CENTRE   (United Kingdom)

^d PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Epicutaneous sensitization; Food allergy; IgE; Oral tolerance; Peanut; Skin

Indexed keywords

CYTOKINE; FOOD ALLERGEN; IMMUNOGLOBULIN E; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DRUG MEGADOSE; EXPOSURE; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PATCH TEST; PEANUT ALLERGY; PRIORITY JOURNAL; PROTEIN INTAKE; SKIN; SKIN SENSITIZATION; TH2 CELL;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ALLERGENS; ANIMALS; ANTIGENS; ARACHIS HYPOGAEA; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; PEANUT HYPERSENSITIVITY; PLANT PROTEINS; SKIN; TH2 CELLS;

EID: 21844458478     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02260.x     Document Type: Article

References (36)

1. Sampson HA. Update on food allergy. J Allergy Clin Immunol 2004; 113:805-19.
2. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361:151-60.
3. Sicherer SH, Sampson HA. Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management. J Allergy Clin Immunol 1999; 104 (Part 2):S114-22.
4. Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003; 112 (Suppl.): S128-39.
5. Wollenberg A, Kraft S, Oppel T, Bieber T. Atopic dermatitis: pathogenetic mechanisms. Clin Exp Dermatol 2000; 25:530-4.
6. Lack G, Fox D, Northstone K, Golding J. Factors associated with the development of peanut allergy in childhood. N Engl J Med 2003; 348:977-85.
7. Schleimer RP, Togias AG. Introduction: systemic aspects of allergic disease. J Allergy Clin Immunol 2000; 106 (Part 2): 191.
8. Sicherer SH, Munoz-Furlong A, Sampson HA. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J Allergy Clin Immunol 2003; 112:1203-7.
9. Kagan RS, Joseph L, Dufresne C et al. Prevalence of peanut allergy in primary-school children in Montreal, Canada. J Allergy Clin Immunol 2003; 112:1223-8.
10. Grundy J, Matthews S, Bateman B, Dean T, Arshad SH. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. J Allergy Clin Immunol 2002; 110:784-9.
11. Hourihane JO, Dean TP, Warner JO. Peanut allergy in relation to heredity, maternal diet, and other atopic diseases: results of a questionnaire survey, skin prick testing, and food challenges. BMJ 1996; 313:518-21.
12. Strid J, Hourihane J, Kimber I, Callard R, Strobel S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol 2004; 34:2100-9.
13. Wang LF, Lin JY, Hsieh KH, Lin RH. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. J Immunol 1996; 156:4077-82.
14. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998; 101:1614-22.
15. Herrick CA, MacLeod H, Glusac E, Tigelaar RE, Bottomly K. Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest 2000; 105:765-75.
16. Herrick CA, Xu L, McKenzie AN, Tigelaar RE, Bottomly K. IL-13 is necessary, not simply sufficient, for epicutaneously induced Th2 responses to soluble protein antigen. J Immunol 2003; 170:2488-95.
17. Werfel T. Skin manifestations in food allergy. Allergy 2001; 56 (Suppl. 67):98-101.
18. Hsieh KY, Tsai CC, Wu CH, Lin RH. Epicutaneous exposure to protein antigen and food allergy. Clin Exp Allergy 2003; 33:1067-75.
19. de Jong E, Spanhaak S, Martens BP, Kapsenberg ML, Penninks AH, Wierenga EA. Food allergen (peanut)-specific TH2 clones generated from the peripheral blood of a patient with peanut allergy. J Allergy Clin Immunol 1996; 98:73-81.
20. Cochet O, Teillaud J, Sautès C, eds. Immunological techniques made easy. Chichester: John Wiley & Sons, 1998.
21. Strid J, Thomson M, Hourihane J, Kimber I, Strobel S. A novel model of sensitization and oral tolerance to peanut protein. Immunology 2004; 113:293-303.
22. Armitage P. Statistical methods in medical research. Oxford: Blackwell, 1971.
23. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107:191-3.
24. Leung DY, Sampson HA, Yunginger JW et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003; 348:986-93.
25. Strobel S, Mowat AM. Immune responses to dietary antigens: oral tolerance. Immunol Today 1998; 19:173-81.
26. Li XM, Serebrisky D, Lee SY et al. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol 2000; 106 (Part 1):150-8.
27. Crespo JF, Rodriguez J. Food allergy in adulthood. Allergy 2003; 58:98-113.
28. Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 2003; 121:345-53.
29. Warner RR, Stone KJ, Boissy YL. Hydration disrupts human stratum corneum ultrastructure. J Invest Dermatol 2003; 120:275-84.
30. Strid J, Strobel S. Skin barrier dysfunction and systemic sensitization to allergens through the skin. Curr Drug Targets - Inflammation Allergy 2005, in press.
31. Perry TT, Conover-Walker MK, Pomes A, Chapman MD, Wood RA. Distribution of peanut allergen in the environment. J Allergy Clin Immunol 2004; 113:973-6.
32. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997; 18:335-43.
33. Garside P, Mowat AM. Oral tolerance. Semin Immunol 2001; 13:177-85.
34. Bilsborough J, Viney JL. Getting to the guts of immune regulation. Immunology 2002; 106:139-43.
35. Li X, Huang CK, Schofield BH et al. Strain-dependent induction of allergic sensitization caused by peanut allergen DNA immunization in mice. J Immunol 1999; 162:3045-52.
36. Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan - DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999; 5:387-91.